Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Addex Therapeutics (ADXN) EPS (Weighted Average and Diluted) (2024)

Addex Therapeutics' EPS (Weighted Average and Diluted) history spans 1 years, with the latest figure at -$242322.6 for Q4 2024.

  • On a quarterly basis, EPS (Weighted Average and Diluted) changed N/A to -$242322.6 in Q4 2024 year-over-year; TTM through Dec 2024 was -$242322.6, a N/A change, with the full-year FY2025 number at -$0.07, down 190.57% from a year prior.
  • EPS (Weighted Average and Diluted) came in at -$242322.6 for Q4 2024, down from -$48.0 in the prior quarter.
  • The five-year high for EPS (Weighted Average and Diluted) was $110272.3 in Q2 2024, with the low at -$242322.6 in Q4 2024.